ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1061

Cardiac Endothelial Cell Transcriptome Analyses Support a Pathological Role of Metabolic and Inflammasome Genes in Anti-SSA/Ro-Associated Congenital Heart Block

Sara Rasmussen1, Robert M. Clancy2 and Jill P. Buyon2, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2NYU School of Medicine, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: endothelial cells, genomics, heart block, inflammasome activation and metabolism

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Innate Immunity and Rheumatic Disease Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The role of Type I IFN in anti-SSA/Ro-associated Congenital Heart Block (CHB) may include an adverse consequence to the cardiac vasculature. One scenario consistent with injury is that the phenotype of cardiac endothelial cells contributes to Caspase-1/Interleukin-1 converting enzyme (inflammasome) to account for chronic levels of inflammatory cytokines and oxidative stress. This study sought to test the hypothesis that anti-SSA/Ro-mediated injury to the vasculature occurs via a Type 1 IFN-enriched environment, which acts on the endothelial cells to upregulate the inflammasome along with metabolical changes contributing to damage by decreasing oxygen to the tissue.

Methods:

Two sources of endothelial cells were studied. In an in vitro approach, cultured HUVECs were evaluated in the presence and absence of supernatants generated from macrophages treated with ssRNA (hY3) since previous studies have identified macrophages as a potential source of IFN in CHB. Both transcriptomic analyses and cellular metabolism as reflected in the extracellular acidification rate (ECAR) and mitochondrial oxygen consumption (OCR) were analyzed using the Seahorse platform. A second in vivo approach used freshly obtained endothelial cells (DAPI negative cells isolated by flow using antibodies to CD31) from a 19 week fetus dying with CHB and an otherwise healthy 22 week heart.

Results:

For the in vitro experiments, IFIT1 (IFN response gene) was significantly increased by 163-fold in HUVECs incubated with hY3 macrophage supernatants compared to HUVECS treated with macrophage supernatants alone (p=0.023, qPCR). The inflammasome components NLRP3 and CASP1 were also significantly increased by 2.8 fold and 2.1 fold in HUVECS treated with hY3 macrophage supernatants vs macrophage supernatants alone (p=0.025, p=0.05, respectively). Reflecting oxidant stress, significant increases in ECAR were observed in the HUVECS treated with hY3 macrophage supernatants compared to macrophage supernatants alone (15±4 mpH/min vs 5±3 mpH/min, p=0.05, N = 3). For bioenergetic health index (BHI), a composite of spare capacity, coupling efficiency, Proton leak and non mitochondrial respiration, there was a trend to be lower EC + hY3 macrophage supernatants vs EC + macrophage supernatants (2.0 vs 3.3, p=0.2, respectively) .

Transcriptomes of the two hearts for each isolated endothelial cell fraction were compared. Based on DAVID annotation, data were organized into clusters of closely related genes. The top GO category was the type I IFN signaling pathway with 5 IFN inducible genes in the top 10. Regarding targeted genes with greater than two-fold upregulation (CHB vs control), there were genes within the inflammasome pathway, including IFN inducible NLRC5, which serves to interact with NLRP3, along with well characterized multiprotein oligomer of the inflammasome such as NLRP3, IRF7, IRF9 & CASP1. Inflammasome precursors including IL18, IL1B, & IL1A were also upregulated.

Conclusion:

Anti-SSA/Ro-induced cardiac injury may include a previously unappreciated effect on the vasculature mediated by IFN. This vascular effect is reflected in the upregulation of metabolic and inflammasome genes.


Disclosure: S. Rasmussen, None; R. M. Clancy, None; J. P. Buyon, None.

To cite this abstract in AMA style:

Rasmussen S, Clancy RM, Buyon JP. Cardiac Endothelial Cell Transcriptome Analyses Support a Pathological Role of Metabolic and Inflammasome Genes in Anti-SSA/Ro-Associated Congenital Heart Block [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/cardiac-endothelial-cell-transcriptome-analyses-support-a-pathological-role-of-metabolic-and-inflammasome-genes-in-anti-ssaro-associated-congenital-heart-block/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-endothelial-cell-transcriptome-analyses-support-a-pathological-role-of-metabolic-and-inflammasome-genes-in-anti-ssaro-associated-congenital-heart-block/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology